# FDA recall D-1276-2019

> **American Health Packaging** · Class II · drug recall initiated 2019-04-08.

## Product

GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by:  American Health Packaging, Columbus, Ohio 43217.  NDC: 68084-295-21

## Reason for recall

Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-1276-2019
- **Recalling firm:** American Health Packaging
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-04-08
- **Report date:** 2019-05-08
- **Termination date:** 2020-11-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbus, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1276-2019

## Citation

> AI Analytics. FDA recall D-1276-2019. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1276-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*